Developing tools for calcium imaging in ITPR2-linked liver pathogenesis
开发 ITPR2 相关肝脏发病机制的钙成像工具
基本信息
- 批准号:10727998
- 负责人:
- 金额:$ 15.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:A kinase anchoring proteinAddressAffectAgonistAnhidrosisAreaBindingCalciumCalcium SignalingCell LineCellsCoupledCytoplasmDependovirusDietEpithelial CellsEventFructoseGeneticHepatocyteITPR1 geneImageInositolJapanLinkLiverLiver RegenerationLobuleMeasurementMeasuresMediatingMedicalMetabolicMetabolic DiseasesMetabolismMissense MutationMitochondriaModelingMonitorMusMutationOrganOutcomeOuter Mitochondrial MembranePathogenesisPatientsPharmaceutical PreparationsPhotonsPhysiologicalPhysiologyPlayPopulationProcessProtein IsoformsProteinsRare DiseasesRattusReporterReportingResearchRoleSatellite VirusesSignal TransductionStructureSystemTacrolimus Binding ProteinsTestingTissuesViralWestern Blottingbile formationcell typefunctional outcomeshuman diseasein vivoinorganic phosphateintravenous injectionintravital imagingliver cell proliferationliver functionliver imagingmouse modelmulti-photonnanonon-alcoholic fatty liver diseasenovelphysiologic modelreceptorresponsescaffoldsensorspatiotemporaltissue injurytooltool developmenttripolyphosphatevector
项目摘要
The liver is a vital organ, central to metabolic functions. Intracellular Ca2+ is a major regulator of
cellular events affecting liver functions. The major Ca2+ release channels present in liver are the
inositol 1, 4, 5-triphosphate (IP3) receptors (ITPR). Of the three ITPR isoforms, ITPR1 and ITPR2
are expressed in hepatocytes. ITPR1 expression corresponds to ~20% of total ITPR present
making ITPR2 the principal Ca2+ release entity in liver. ITPR2 has been linked to key liver
functions like bile formation, liver regeneration and hepatocyte proliferation. Reduced ITPR2
expression has been observed in a rat model of non-alcoholic fatty liver disease. The importance
of ITPR2 as a Ca2+ release channel with downstream effects on liver functions has become even
more interesting with the emergence of ER-mitochondria contacts (ERMC). We have previously
shown that ITPR2 has been the most effective in local Ca2+ transfer at ERMC in cell lines. Recent
studies indicate ERMC mediated local signaling and Ca2+ transfer to be associated with metabolic
disorders involving liver. In summary, broad evidence indicates a fundamental role of ITPR2
in various liver functions, which are likely directly relevant for ITPR2-linked human
diseases, but the underlying mechanisms remained difficult to study in physiological
models. To solve this problem, we propose to create a novel toolkit that includes a genetic
mouse model combined with viral delivery of fluorescent protein reporters for recording
global and local cytoplasmic and mitochondrial Ca2+ signaling. We intend to introduce tools
in the form of inducible and liver-specific ITPR2KO mouse model and subject hepatocytes to
intracellular and intra-organellar Ca2+ measurements which will enable understanding the function
of ITPR2 in Ca2+ signaling pertaining to liver physiology. We intend to deliver fluorescent
cytoplasmic and mitochondrial Ca2+ probes with liver-targeted adeno-associated virus 8 (AAV8)
that will allow intra-vital imaging to monitor spontaneous and agonist induced Ca2+ changes in live
liver tissue. Furthermore, to study the ERMC local signaling we have developed drug-inducible
synthetic ER-mitochondria linker constructs tagged with Ca2+ sensing fluorescent proteins. In
order to understand the role of ITPR2 in ERMC structure and functions in the context of liver
physiology, we plan to express the synthetic linkers in the inducible ITPR2KO mouse model.
Thus, our project will yield a novel toolkit to study ITPR2 in the context of both global and local
cytoplasmic and mitochondrial Ca2+ signaling that is expected to be broadly useful for determining
the outcome of ITPR2 mutations and other ITPR2-linked conditions in physiological models.
肝脏是一个重要的器官,是代谢功能的中心。细胞内Ca 2+是一种主要的调节因子,
影响肝功能的细胞事件。肝脏中主要的钙释放通道是
肌醇1,4,5-三磷酸(IP 3)受体(ITPR)。在三种ITPR亚型中,ITPR 1和ITPR 2
在肝细胞中表达。ITPR 1表达相当于总ITPR的约20%
使ITPR 2成为肝脏中主要的Ca 2+释放实体。ITPR 2与关键肝脏有关
功能如胆汁形成、肝再生和肝细胞增殖。降低ITPR 2
在非酒精性脂肪肝病的大鼠模型中观察到表达。的重要性
ITPR 2作为Ca 2+释放通道对肝功能的下游作用已经变得均匀
随着ER-线粒体接触(ERMC)的出现,这一点更加有趣。我们先前已经
表明ITPR 2在细胞系ERMC的局部Ca 2+转移中是最有效的。最近
研究表明ERMC介导的局部信号传导和Ca 2+转移与代谢相关,
涉及肝脏的疾病总之,广泛的证据表明ITPR 2的基本作用
在各种肝功能中,这可能与ITPR 2相关的人直接相关。
疾病,但潜在的机制仍然难以在生理学上研究。
模型为了解决这个问题,我们建议创建一个新的工具包,其中包括一个基因,
用于记录的与病毒递送荧光蛋白报告基因组合的小鼠模型
整体和局部细胞质和线粒体Ca 2+信号传导。我们打算引进工具
以诱导型和肝脏特异性ITPR 2KO小鼠模型的形式,
细胞内和细胞器内的Ca 2+测量,这将有助于了解功能
ITPR 2在与肝脏生理学有关的Ca 2+信号传导中的作用。我们打算提供荧光
肝靶向腺相关病毒8(AAV 8)的细胞质和线粒体Ca 2+探针
这将允许活体内成像监测肝中自发和激动剂诱导的Ca 2+变化
肝组织此外,为了研究ERMC局部信号传导,我们开发了药物诱导的
用Ca 2+感应荧光蛋白标记的合成ER-线粒体接头构建体。在
为了了解ITPR 2在肝脏ERMC结构和功能中的作用,
为了进一步研究ITPR 2KO小鼠的生理学特性,我们计划在诱导型ITPR 2KO小鼠模型中表达合成接头。
因此,我们的项目将产生一个新的工具包,研究ITPR 2在全球和地方的背景下,
细胞质和线粒体Ca 2+信号传导,预期可广泛用于确定
ITPR 2突变和其他ITPR 2相关疾病在生理模型中的结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gyorgy Hajnoczky其他文献
Gyorgy Hajnoczky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gyorgy Hajnoczky', 18)}}的其他基金
Mitochondrial Calcium Uniporter in Signaling and Dynamics
线粒体钙单向转运蛋白在信号传导和动力学中的作用
- 批准号:
10720242 - 财政年份:2023
- 资助金额:
$ 15.6万 - 项目类别:
(PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting
(PQ5) VDAC2 异质性与肝肿瘤生长和靶向的相关性
- 批准号:
10395472 - 财政年份:2018
- 资助金额:
$ 15.6万 - 项目类别:
(PQ5) Relevance of VDAC2 heterogeneity for hepatic tumor growth and targeting
(PQ5) VDAC2 异质性与肝肿瘤生长和靶向的相关性
- 批准号:
9924258 - 财政年份:2018
- 资助金额:
$ 15.6万 - 项目类别:
Molecular Mechanisms of Mitochondrial Ca2+ Transport
线粒体 Ca2 运输的分子机制
- 批准号:
9000157 - 财政年份:2015
- 资助金额:
$ 15.6万 - 项目类别:
Molecular Mechanisms of Mitochondrial Ca2+ Transport
线粒体 Ca2 运输的分子机制
- 批准号:
9264336 - 财政年份:2015
- 资助金额:
$ 15.6万 - 项目类别:
Redox Regulation of Intracellular Calcium Signaling
细胞内钙信号传导的氧化还原调节
- 批准号:
9022475 - 财政年份:2015
- 资助金额:
$ 15.6万 - 项目类别:
Redox Regulation of Intracellular Calcium Signaling
细胞内钙信号传导的氧化还原调节
- 批准号:
8905057 - 财政年份:2015
- 资助金额:
$ 15.6万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 15.6万 - 项目类别:
Research Grant